As of 2024-12-14, the Relative Valuation of BioPharma Credit PLC (BPCR.L) is 0.93 USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.86 USD, the upside of BioPharma Credit PLC based on Relative Valuation is 8.3%.
The range of the Relative Valuation is 0.86 - 1.03 USD.
| Range | Selected | |
| Trailing P/E multiples | 10.0x - 11.2x | 10.4x |
| Forward P/E multiples | 11.6x - 13.5x | 12.2x |
| Fair Price | 0.86 - 1.03 | 0.93 |
| Upside | 0.0% - 20.1% | 8.3% |
| Date | P/E |
| 2024-12-12 | 9.32 |
| 2024-12-11 | 9.36 |
| 2024-12-10 | 9.38 |
| 2024-12-09 | 9.47 |
| 2024-12-06 | 9.53 |
| 2024-12-05 | 9.62 |
| 2024-12-04 | 9.55 |
| 2024-12-03 | 9.55 |
| 2024-12-02 | 9.58 |
| 2024-11-29 | 9.55 |
| 2024-11-28 | 9.62 |
| 2024-11-27 | 9.64 |
| 2024-11-26 | 9.58 |
| 2024-11-25 | 9.62 |
| 2024-11-22 | 9.62 |
| 2024-11-21 | 9.62 |
| 2024-11-20 | 9.53 |
| 2024-11-19 | 9.42 |
| 2024-11-18 | 9.40 |
| 2024-11-15 | 9.36 |
| 2024-11-14 | 9.45 |
| 2024-11-13 | 9.42 |
| 2024-11-12 | 9.53 |
| 2024-11-11 | 9.47 |
| 2024-11-08 | 9.45 |
| 2024-11-07 | 9.42 |
| 2024-11-06 | 9.29 |
| 2024-11-05 | 9.36 |
| 2024-11-04 | 9.38 |
| 2024-11-01 | 9.36 |
| 2024-10-31 | 9.36 |
| 2024-10-30 | 9.25 |
| 2024-10-29 | 9.25 |
| 2024-10-28 | 9.34 |
| 2024-10-25 | 9.34 |
| 2024-10-24 | 9.31 |
| 2024-10-23 | 9.36 |
| 2024-10-22 | 9.36 |
| 2024-10-21 | 9.40 |
| 2024-10-18 | 9.55 |
| 2024-10-17 | 9.55 |
| 2024-10-16 | 9.45 |
| 2024-10-15 | 9.47 |
| 2024-10-14 | 9.51 |
| 2024-10-11 | 9.66 |
| 2024-10-10 | 9.68 |
| 2024-10-09 | 9.68 |
| 2024-10-08 | 9.47 |
| 2024-10-07 | 9.58 |
| 2024-10-04 | 9.60 |